Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy

被引:46
作者
Taylor, Roseanne M.
Lee, Jean Pyo
Palacino, James J.
Bower, Kate A.
Li, Jianxue
Vanier, Marie T.
Wenger, David A.
Sidman, Richard L.
Snyder, Evan Y. [1 ]
机构
[1] Burnham Inst Med Res, Program Stem Cells & Regenerat, La Jolla, CA 92037 USA
[2] Univ Sydney, Fac Vet Sci, Dept Anim Sci, Sydney, NSW, Australia
[3] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA
[5] Lyon Sud Hosp, Fdn Gillet Merieux, Pierre Benite, France
[6] INSERM 189, Lyon Sud Med Sch, Oullins, France
[7] Jefferson Med Coll, Dept Neurol, Philadelphia, PA USA
关键词
childhood neurodegenerative diseases; gene therapy; mouse and human neural stem cells; myelination; oligodendrocytes; psychosine;
D O I
10.1111/j.1471-4159.2006.03986.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
While transplanted neural stem cells (NSCs) have been shown to hold promise for cell replacement in models of a number of neurological disorders, these examples have typically been under conditions where the host cells become dysfunctional due to a cell autonomous etiology, i.e. a 'sick' cell within a relatively supportive environment. It has long been held that cell replacement in a toxic milieu would not likely be possible; donor cells would succumb in much the same way as endogenous cells had. Many metabolic diseases are characterized by this situation, suggesting that they would be poor targets for cell replacement therapies. On the other hand, models of such diseases could prove ideal for testing the capacity for cell replacement under such challenging conditions. In the twitcher (twi ) mouse - as in patients with Krabbe or globoid cell leukodystrophy (GLD), for which it serves as an authentic model - loss of galactocerebrosidase (GalC) activity results in the accumulation of psychosine, a toxic glycolipid. Twi mice, like children with GLD, exhibit inexorable neurological deterioration presumably as a result of dysfunctional and ultimately degenerated oligodendrocytes with loss of myelin. It is believed that GLD pathophysiology is related to a psychosine-filled environment that kills not only host oligodendrocytes but theoretically any new cells placed into that milieu. Through the implantation of NSCs into the brains of both neonatal and juvenile/young adult twi mice, we have determined that widespread oligodendrocyte replacement and remyelination is feasible. NSCs appear to be intrinsically resistant to psychosine - more so in their undifferentiated state than when directed ex vivo to become oligodendrocytes. This resistance can be enhanced by engineering the NSCs to over-express GalC. Some twi mice grafted with such engineered NSCs had thicker white tracts and lived 2-3 times longer than expected. While their brains had detectable levels of GalC, it was probably more significant that their psychosine levels were lower than in twi mice that died at a younger age. This concept of resistance based on differentiation state extended to human NSCs which could similarly survive within the twi brain. Taken together, these results suggest a number of points regarding cellular therapies against degenerative diseases with a prominent cell non-autonomous component: Cell replacement is possible if cells resistant to the toxic environment are employed. Furthermore, an important aspect of successful treatment will likely be not only cell replacement but also cross-correction of host cells to provide them with enzyme activity and hence resistance. While oligodendrocyte replacement alone was not a sufficient treatment for GLD (even when extensive), the replacement of both cells and molecules - e.g. with NSCs that could both become oligodendrocytes and 'pumps' for GalC - emerges as a promising basis for a multidisciplinary strategy. Most neurological disease are complex in this way and will likely require multifaceted approaches, perhaps with NSCs serving as the 'glue'.
引用
收藏
页码:1585 / 1599
页数:15
相关论文
共 46 条
[1]   Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas [J].
Aboody, KS ;
Brown, A ;
Rainov, NG ;
Bower, KA ;
Liu, SX ;
Yang, W ;
Small, JE ;
Herrlinger, U ;
Ourednik, V ;
Black, PM ;
Breakefield, XO ;
Snyder, EY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12846-12851
[2]   Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model [J].
Björklund, LM ;
Sánchez-Pernaute, R ;
Chung, SM ;
Andersson, T ;
Chen, IYC ;
McNaught, KS ;
Brownell, AL ;
Jenkins, BG ;
Wahlestedt, C ;
Kim, KS ;
Isacson, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2344-2349
[3]   COOPERATION BETWEEN 2 GROWTH-FACTORS PROMOTES EXTENDED SELF-RENEWAL AND INHIBITS DIFFERENTIATION OF OLIGODENDROCYTE TYPE-2 ASTROCYTE (O-2A) PROGENITOR CELLS [J].
BOGLER, O ;
WREN, D ;
BARNETT, SC ;
LAND, H ;
NOBLE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6368-6372
[4]   LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism [J].
Cartwright, P ;
McLean, C ;
Sheppard, A ;
Rivett, D ;
Jones, K ;
Dalton, S .
DEVELOPMENT, 2005, 132 (05) :885-896
[5]   HEREDITARY LEUCODYSTROPHY IN THE MOUSE - THE NEW MUTANT TWITCHER [J].
DUCHEN, LW ;
EICHER, EM ;
JACOBS, JM ;
SCARAVILLI, F ;
TEIXEIRA, F .
BRAIN, 1980, 103 (SEP) :695-710
[6]   Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease [J].
Escolar, ML ;
Poe, MD ;
Provenzale, JM ;
Richards, KC ;
Allison, J ;
Wood, S ;
Wenger, DA ;
Pietryga, D ;
Wall, D ;
Champagne, M ;
Morse, R ;
Krivit, W ;
Kurtzberg, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (20) :2069-2081
[7]   Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes [J].
Flax, JD ;
Aurora, S ;
Yang, CH ;
Simonin, C ;
Wills, AM ;
Billinghurst, LL ;
Jendoubi, M ;
Sidman, RL ;
Wolfe, JH ;
Kim, SU ;
Snyder, EY .
NATURE BIOTECHNOLOGY, 1998, 16 (11) :1033-1039
[8]   Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy [J].
Givogri, MI ;
Galbiati, F ;
Fasano, S ;
Amadio, S ;
Perani, L ;
Superchi, D ;
Morana, P ;
Del Carro, U ;
Marchesini, S ;
Brambilla, R ;
Wrabetz, L ;
Bongarzone, E .
JOURNAL OF NEUROSCIENCE, 2006, 26 (12) :3109-3119
[9]   Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway [J].
Imitola, J ;
Raddassi, K ;
Park, KI ;
Mueller, FJ ;
Nieto, M ;
Teng, YD ;
Frenkel, D ;
Li, JX ;
Sidman, RL ;
Walsh, CA ;
Snyder, EY ;
Khoury, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (52) :18117-18122
[10]   Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis [J].
Jeyakumar, M ;
Thomas, R ;
Elliot-Smith, E ;
Smith, DA ;
van der Spoel, AC ;
d'Azzo, A ;
Perry, VH ;
Butters, TD ;
Dwek, RA ;
Platt, FM .
BRAIN, 2003, 126 :974-987